Fast-acting insulin from snail venom


Monday, 19 September, 2016

Fast-acting insulin from snail venom

Australian and US scientists have found that peptide molecules from the venom of a marine cone snail, common to northern Australia, contain an insulin-like natural protein called Con-Ins G1 that can operate more rapidly than human insulin.

The findings build on earlier studies which reported that the marine cone snail Conus geographus used an insulin-based venom to trap its prey. Unsuspecting fish prey would swim into the invisible trap and immediately become immobilised in a state of hypoglycaemic shock induced by the venom.

Now, the researchers have used the Australian Synchrotron to create and analyse the 3D structure of this cone snail venom insulin protein. Their results have been published in the journal Nature Structural & Molecular Biology.

“We found that cone snail venom insulins avoid the structural changes that human insulins undergo in order to function — they are essentially primed and ready to bind to their receptors,” said Associate Professor Mike Lawrence from the Walter and Eliza Hall Institute, who added that human insulins could be considered ‘clunky’ by comparison.

“The structure of human insulins contain an extra ‘hinge’ component that has to open before any ‘molecular handshake’ or connection between insulin and receptor can take place,” he said.

Comparison of the structures of insulin in Conus geographus (red/white) and in humans (blue/white and green). The green B-chain terminal segment is absent in the C. geographus insulin. Image courtesy of Mike Lawrence, WEHI.

What’s particularly exciting is the fact that Con-Ins G1 is able to bind to human insulin receptors. As explained by Dr Helena Safavi-Hemami from the University of Utah, Con-Ins G1 can ‘switch on’ human insulin cell signalling pathways, which could hold the key to developing ultrafast-acting insulins for more efficient diabetes management.

“Now we can look at the human insulin and see if we can make it more snail-like,” she said.

The team’s next step is to measure how quickly snail insulin, or a modified human insulin, would work when injected into an organism. Fish are affected almost instantly because the insulin passes over the gills. In humans, the process may take five minutes — though this would still be substantially faster than the 15–30 minutes required for the fastest-acting insulin currently available.

“It’s really about learning from nature,” concluded Danny Chou from the University of Utah.

Top image caption: The venomous Conus geographus hunting a fish. Image courtesy of Baldomero Olivera, University of Utah.

Related News

A pre-emptive approach to treating leukaemia relapse

The monitoring of measurable residual disease (MRD), medication and low-dose chemotherapy is...

Long COVID abnormalities appear to resolve over time

Researchers at UNSW's Kirby Institute have shown that biomarkers in long COVID patients have...

RNA-targeted therapy shows promise for childhood dementia

Scientists have shown that a new RNA-targeted therapy can halt the progression of a specific type...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd